Grey Wolf Health Corp. (TSXV:WOLF)

Canada · Delayed Price · Currency is CAD

1.750

0.00 (0.00%)

At close: Jul 2, 2026

80.41% (1Y)

Market Cap	60.36M +65.0%
Revenue (ttm)	36.60M +27.5%
Net Income	1.77M +192.9%
EPS	0.05 +211.9%
Shares Out	34.49M
PE Ratio	33.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,014
Open	1.750
Previous Close	1.750
Day's Range	1.750 - 1.750
52-Week Range	0.970 - 1.800
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Grey Wolf Health

Grey Wolf Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under the SEDA... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

CEO Angela Cechetto

Country Canada

Stock Exchange TSX Venture Exchange

Ticker Symbol WOLF

Full Company Profile

Financial Performance

In 2025, Grey Wolf Animal Health's revenue was 35.76 million, an increase of 33.30% compared to the previous year's 26.83 million. Earnings were 1.66 million, an increase of 135.11%.

Financial Statements